Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

INVAGEN PHARMS

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 28
  • 0 comments

FDA approve NABUMETONE

Comment Full text

FOSUN PHARMA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 34
  • 0 comments

FDA approve ASPIRIN; BUTALBITAL; CAFFEINE

Comment Full text

SAGENT PHARMS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 32
  • 0 comments

FDA approve KETOROLAC TROMETHAMINE

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 31
  • 0 comments

FDA approve MELOXICAM

Comment Full text

SUN PHARM

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve DILTIAZEM HYDROCHLORIDE

Comment Full text

STEVENS J

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 24
  • 0 comments

FDA approve ASPIRIN; METHOCARBAMOL

Comment Full text

AUROBINDO PHARMA USA

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 23
  • 0 comments

FDA approve NABUMETONE

Comment Full text

DR REDDYS LABS INC

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 27
  • 0 comments

FDA approve MELOXICAM

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 29
  • 0 comments

FDA approve INDOMETHACIN

Comment Full text

TARO

  • FDA Approval
  • Nov. 25, 2024, 09:49 UTC
  • 22
  • 0 comments

FDA approve ETODOLAC

Comment Full text
  • Previous
  • 199
  • 200
  • 201
  • 202
  • 203
  • Next

Search

News categories

  • Technical Exchange News(9888)
  • Event(407)
  • SEC News(167424)
  • FDA Approval(9345)
  • Company Report(721)
  • Business News(111256)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin